Deutsch English Français

Contact

EP3300501

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3300501

EP3300501 - NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 25.12.2020 Database last updated on 14.09.2024
Former	Request for examination was made Status updated on 02.03.2018
Former	The international publication has been made Status updated on 04.11.2016
Most recent event Tooltip	29.05.2024	New entry: Despatch of examination report + time limit
Applicant(s)	For all designated states Pimera, Inc. 3210 Merryfield Row San Diego, California 92121 / US
	[2018/14]
Inventor(s)	01 / HADDACH, Mustapha 3210 Merryfield Row San Diego, California 92121 / US
	[2018/14]
Representative(s)	Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB
	[N/P]
Former [2018/14]	Barker Brettell LLP 100 Hagley Road Edgbaston Birmingham B16 8QQ / GB
Application number, filing date	16759401.9	02.03.2016
	[2018/14]
	WO2016US20418
Priority number, date	US201562128208P	04.03.2015 Original published format: US 201562128208 P
	[2018/14]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2016141042
	Date:	09.09.2016
	Language:	EN
	[2016/36]
	Type:	A2 Application without search report
	No.:	EP3300501
	Date:	04.04.2018
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 09.09.2016 takes the place of the publication of the European patent application.
	[2018/14]
Search report(s)	International search report - published on:	KR	03.11.2016
	(Supplementary) European search report - dispatched on:	EP	19.03.2019
Classification	IPC:	C07D487/14, A61K31/4353, A61P35/00	[2019/01]
	CPC:	C07D471/14 (EP,US); A61K31/4353 (US); A61P35/00 (EP,US); C07D471/04 (EP,US); C07D471/22 (EP,US); C07D487/14 (EP,US)
	Former IPC [2018/14]	C07D471/14, C07D487/14, C07D403/04, C07D403/14, A61K31/4375, A61K31/519, A61K31/4985, A61K31/5025
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/14]
Title	German:	NEUARTIGE ZUSAMMENSETZUNGEN, VERWENDUNGEN UND VERFAHREN ZUR HERSTELLUNG DAVON	[2018/14]
	English:	NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM	[2018/14]
	French:	NOUVELLES COMPOSITIONS, LEURS UTILISATIONS ET LEURS PROCÉDÉS DE PRÉPARATION	[2018/14]
Entry into regional phase	01.09.2017	National basic fee paid
	01.09.2017	Search fee paid
	01.09.2017	Designation fee(s) paid
	16.02.2018	Examination fee paid
Examination procedure	01.09.2017	Date on which the examining division has become responsible
	deleted	Deletion: Application deemed to be withdrawn, date of legal effect [2018/14]
	16.02.2018	Examination requested [2018/14]
	11.10.2019	Amendment by applicant (claims and/or description)
	13.01.2021	Despatch of a communication from the examining division (Time limit: M04)
	20.05.2021	Reply to a communication from the examining division
	30.08.2021	Despatch of a communication from the examining division (Time limit: M06)
	07.06.2022	Reply to a communication from the examining division
	28.05.2024	Despatch of a communication from the examining division (Time limit: M04)
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	07.06.2022	Request for further processing filed
	07.06.2022	Full payment received (date of receipt of payment) Request granted
	17.06.2022	Decision despatched
	The application is deemed to be withdrawn due to non-payment of the examination fee
	16.02.2018	Request for further processing filed
	16.02.2018	Full payment received (date of receipt of payment) Request granted
	01.03.2018	Decision despatched
	16.02.2018	Request for further processing filed
	16.02.2018	Full payment received (date of receipt of payment) Request granted
	01.03.2018	Decision despatched
Fees paid	Renewal fee
	29.03.2018	Renewal fee patent year 03
	27.03.2019	Renewal fee patent year 04
	27.03.2020	Renewal fee patent year 05
	29.03.2021	Renewal fee patent year 06
	28.03.2022	Renewal fee patent year 07
	27.03.2023	Renewal fee patent year 08
	27.03.2024	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[I]WO2009046383 (CYLENE PHARMACEUTICALS INC [US], et al) [I] 1-10,14,15 * claims 1, 31 *;
		[A] - BEAULIEU ET AL, "Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, (20070214), vol. 17, no. 5, doi:10.1016/J.BMCL.2006.12.017, ISSN 0960-894X, pages 1233 - 1237, XP005888454 [A] 1-10,14,15 * table 1, compounds 7a-d * DOI: http://dx.doi.org/10.1016/j.bmcl.2006.12.017
		[X] - WOLFGANG-R. KNAPPE, "Photochemie des 10-Phenylisoalloxazins: Intramolekulare Singulett- und intermolekulare Triplett-Reaktionen", CHEMISCHE BERICHTE, DE, (19740501), vol. 107, no. 5, doi:10.1002/cber.19741070520, ISSN 0009-2940, pages 1614 - 1636, XP055524260 [X] 1,2 * page 1625; compound 17a * DOI: http://dx.doi.org/10.1002/cber.19741070520
		[X] - V I Shvedov ET AL, "Synthesis of derivatives of pyrazino[1,2-a]benzimidazole, aza analogs of[beta]-carboline", (19691031), URL: https://link.springer.com/content/pdf/10.1007/BF00762071.pdf, (20181115), XP055524256 [X] 1,2 * compound IV *
	International search	[X]WO0228860 (BRISTOL MYERS SQUIBB CO [US], et al) [X] 19 * See abstract; pages 25-26, 34, 46. *;
		[PX]WO2015172123 (HADDACH MUSTAPHA [US]) [PX] 1-15, 17-21* See abstract; claims 1-33. *;
		[XA] - Chemical Abstract, (19961211), Database accession no. 183858-24-4, URL: STN, XP 055409388 [X] 1-2 * ,. See the structures. * [A] 3-15, 17-21
		[ ] - CHEMICAL ABSTRACT, (19961211), Database accession no. 183858-23-3, URL: STN, XP 055409391
		[XA] - Chemical Abstract, (19841218), Database accession no. 93438-49-4, URL: STN, XP055410392 [X] 1-2 * . See the structure. * [A] 3-15, 17-21
		[XA] - ZANZOUL, A. et al., "A benzimidazopyridoquinoxaline as promising scaffold for G-quadruplex DNA targeting", Medicinal chemistry research, (20140000), vol. 23, pages 4042 - 4049, XP 055327267 [X] 19-20 * . See abstract; page 4042; scheme 1. * [A] 1-15, 17-18, 21
		[X] - ANDALOUSSI, M. et al., "Novel imidazo[1,2-a]naphthyridinic systems (Part 1): Synthesis, antiproliferative and DNA-intercalating activities", Eur. J. Med. Chem., (20080000), vol. 43, pages 2505 - 2517, XP 025571383 [X] 19 * . See abstract; table 1. *
		[A] - MOGILAIAH, K. et al., "Synthesis of some novel bridgehead nitrogen heterocyclic systems containing 1,8-naphthyridine moiety", Indian J. Chem., (20030000), vol. 42 B, pages 192 - 194, XP 055236419 [A] 1-15, 17-21 * . See scheme 1, compound 5. *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p